Positive leadership communication can be an effective tool to reduce turnover and burnout among employees in the healthcare ...

Following COVID-19 vaccination, most patients with MS do not face an increased risk for relapse requiring corticosteroid therapy.

Multiple myeloma patients with COVID-19 have high rates of hospitalization, ICU admission, and death, according to researchers.

Patients with PAH saw significant improvement in pulmonary vascular resistance with use of MK-5475, an inhaled soluble guanylate cyclase stimulator.

HCV testing was conducted in fewer than half of perinatally exposed children, with the lowest odds observed in Black, Asian/Pacific Islander, and Hispanic/Latinx populations.

The U.S. government is offering another round of free COVID-19 tests, which will be available by the end of September.

Gamified digital mental health interventions (DMHIs) may offer benefits for youth with attention-deficit/hyperactivity disorder (ADHD) or depressive disorder.

SGLT-2 inhibitors were associated with the lowest risk for incidental dementia relative to DPP-4 inhibitors and GLP-1RAs in type 2 diabetes.

Neffy, an intranasal formulation of epinephrine, is now available for emergency treatment of type I allergic reactions.

The aTIV vaccine provides better protection against influenza-related medical encounters than the HD-TIV vaccine in high-risk older adults.

The risk for hidradenitis suppurativa development was reduced among adults who quit smoking and maintained a smoke-free status.

Reduced AMR proportions were noted for multiple pathogens from 2007 to 2019, but some previously declining trends have reversed course since the COVID-19 pandemic.